Insulet (PODD) Current Deferred Revenue (2010 - 2019)

Insulet has reported Current Deferred Revenue for 10 years, with the latest figure at $1.2 million in Q1 2019.

• For the quarter ending Q1 2019, Current Deferred Revenue fell 57.46% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2019 stood at $1.2 million (down 57.46% YoY), and the FY2018 full-year result was $1.2 million, down 49.75% from the prior year.
• Current Deferred Revenue for Q1 2019 stood at $1.2 million, up from $1.2 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $2.8 million in Q1 2018, with the low at $1.1 million in Q1 2017.
• Historically, Current Deferred Revenue has averaged $1.9 million across 5 years, with a median of $1.9 million in 2016.
• Annual changes were most pronounced in 2015 — Current Deferred Revenue surged 205.07% — and 2019, when it tumbled 57.46%.
• Insulet's Current Deferred Revenue stood at $2.4 million in 2015, then dropped by 19.53% to $1.9 million in 2016, then grew by 24.0% to $2.4 million in 2017, then slumped by 49.75% to $1.2 million in 2018, then increased by 0.93% to $1.2 million in 2019.
• The last three Current Deferred Revenue figures came in at $1.2 million (Q1 2019), $1.2 million (Q4 2018), and $2.2 million (Q3 2018), per Business Quant data.